Barely Significant
← all excerpts

Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis.

Front Pharmacol · 2021 · PMC8493251 · PMID 34630076

Europe PMCDOI
1
hedged sentence
0.7000
closest p · 14.0× alpha
0.7000
boldest claim

The sentences

showed a trendp = 0.70not close (p > 0.1)
Analysis by the subgroup showed a trend of increased risk of hypertension, without significant results, for bosutinib and dasatinib with an RR of 1.11 (95% CI; 0.64–1.93, I 2 = 25%, z = 0.39, p = 0.70) and 1.50 (95% CI; 0.89–2.54, I 2 = 0%, z = 1.52, p = 0.13), respectively.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.